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Carotid artery stenting is safe and associated with
comparable outcomes in men and women
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Objective: Historically, large randomized controlled studies looking at carotid endarterectomy (CEA) have indicated an
increased perioperative risk for women when gender subgroup analysis was performed. However, the outcomes of carotid
stenting in women as compared to men have not been adequately investigated. We sought to compare the safety and
efficacy of carotid angioplasty and stenting (CAS) when performed in women as compared to men.
Methods: Procedures, complications, demographics, co-morbidities, and follow-up data from carotid stenting procedures
performed in a bi-campus divisionwere entered into a prospective database and then retrospectively supplementedwith stored
angiographic image data and reviewed. Arterial anatomic characteristics evaluated using angiographic images were: common
carotid/internal carotid lesion length ratio, common carotid/internal carotid diameter, index lesion length, common
carotid/internal carotid artery tortuosity, and lesion and aortic arch calcification. Outcomes compared included groin
complications, postoperative pressor requirements, length of stay, restenosis, stroke, myocardial infarction (MI), and death.
Results: Between 2003 and 2008, 228 patients underwent 238 procedures. Cerebral protection devices and self-
expanding stents were placed in all patients. A total of 97 percutaneous interventions performed in 93 women were
compared with 141 interventions in 135 men. Mean age in women was 71.8  9.2 years, in men was 72.2  9.1 years
(P > .99); 44.3% of women and 34.7% of men had symptomatic disease (P  .14). Preoperative demographics and
co-morbidities did not differ significantly between genders, with the exception of hypertension (83.0% of males vs 96.7%
of females, P .001), and history of coronary artery bypass grafting (31.8% of males vs 16.1% of females, P .01). There
were no significant differences seen in anatomic arterial characteristics, though there was a trend towards women having
larger internal carotid to common carotid diameter ratios (0.65 vs 0.62) andmore plaques isolated to the common carotid
segment (9.5% vs 6.9%). There were no significant differences seen in overall 30-day peri-procedural stroke rate (2.1% in
women and 4.2% in men, P  .48), death rate (0 % vs 0.7%, P > .99), or cardiac events (3.2% vs 0.7%, P  .3). The
combined 30-day stroke, death, and MI rate was 5.7% for males compared to 5.4% for females (P > .99). There were no
differences observed in the long-term survival, stroke-free survival, or restenosis between genders.
Conclusion: Despite previous concerns over adverse outcomes in women undergoing carotid endarterectomy, from our
data, carotid stenting appears to be a safe modality in women with equivalent outcomes when compared to men. (J Vasc
Surg 2009;49:315-24.)Carotid artery interventions aim to prevent cerebrovas-
cular events in the distribution of the internal carotid artery
(ICA). For the past 2 decades, large-scale trials have studied
when to intervene when faced with extra-cranial carotid
stenoses.1-5 As new endovascular procedures are being
developed for the treatment of carotid lesions, carotid
angioplasty and stenting (CAS) trials are attempting to
define the role of stenting in the management of these
lesions.6-9 Many of the earlier investigations into carotid
interventions have failed to adequately analyze the effect of
gender on the outcome of the procedure, or failed to show
a benefit for women, calling into question the utility of these
interventions in female patients. The initial reports of the two
most frequently-cited trials regarding the use of carotid end-
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doi:10.1016/j.jvs.2008.08.110arterectomy (CEA) in symptomatic patients, theNorthAmer-
ican Symptomatic Carotid Endarterectomy Trial (NASCET),
and the European Carotid Surgery Trial (ECST), both omit-
ted subgroup analysis with regard to gender.2,3 Additionally,
in both trials, one-third or fewer of the patients were females.
Subgroup analysis of the combined dataset for these studies
via the Carotid Endarterectomy Trialists’ Collaboration
(CETC), showed women with 70% stenosis did benefit
fromCEA, but only if they underwent surgery within 2 weeks
of their symptoms, compared to men who benefited for
longer than 12 weeks.10,11
The largest trials supporting the use of CEA in asymp-
tomatic patients, the VACooperative Trial, the Asymptom-
atic Carotid Atherosclerosis Study (ACAS), and the Asymp-
tomatic Carotid Surgery Trial (ACST) also failed to support
CEA in asymptomatic women. The VA Cooperative Trial
studied only men, the ACAS failed to show a benefit due to
an almost threefold higher perioperative complication rate
in women, and the ACST long-term non-perioperative risk
reduction gained by women (4.1%) was made largely irrel-
evant when compared to the perioperative stroke and death
rate (3.8%).1,4,5 In summary, all of the large carotid endar-
terectomy trials showed decreased or no benefit in women
when compared to men mostly because these trials were
underpowered to show any utility in the relatively small
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term benefit was undermined by the high perioperative
morbidity seen in women.
With regard to carotid stenting, the Stenting and An-
gioplasty with Protection in Patients at High Risk for
Endarterectomy (SAPPHIRE) trial, has recently reported
long-term non-inferiority of CAS compared to CEA.6,12
However, it too did not separately analyze outcomes for
women, and only one-third of those patients were female.
Even fewer (30%) of the patients were female in the
Stent-Protected Percutaneous Angioplasty Versus Carotid
Endarterectomy (SPACE) trial, and the women suffered a
larger difference in periprocedural complication rates be-
tween CAS and CEA (1.71%) than men (0.04%).7 The
Endarterectomy vs Stenting in Patients with Symptomatic
Severe Carotid Stenosis (EVA-3S) trial also had 30%
females, and did not make any gender-specific observa-
tions.8
The lack of data in major trials regarding the benefit of
carotid interventions in women prompted our group to
study the outcomes of CAS in women.We therefore sought
to investigate the safety, feasibility, and efficacy of the
carotid angioplasty and stenting experience in our division
with regard to gender.
METHODS
All patients who underwent carotid angioplasty and
stenting betweenNovember 2002 andMarch 2008 at New
York Presbyterian Hospital were included in this study. A
total of 228 patients underwent 238 procedures involving
cerebral angiography, carotid angioplasty, and trans-catheter
carotid stent deployment.
All patients underwent CAS for symptomatic stenoses
50% or asymptomatic lesions 80% and were considered
to be at an increased risk for standard CEA.High-risk status
was determined by either medical comorbidities (Goldman
class II or III,13 American Society of Anesthesiologists
[ASA] class III or IV14), severe pulmonary disease, or
anatomic factors including history of neck irradiation, spi-
nal immobility with an inability to flex the neck beyond
neutral or a kyphotic deformity, prior ipsilateral CEA,
contralateral carotid occlusion, or high lesion location in
the ICA. The degree of stenosis was determined by preop-
erative duplex ultrasound scan (using the University of
Washington criteria),15,16 magnetic resonance angiogra-
phy (MRA), or cerebral angiography. Preoperative lesion
characteristics and postoperative surveillance were evalu-
ated with duplex ultrasonography scan in our non-invasive
vascular laboratories by ultrasound technicians experienced
in carotid imaging. Vascular surgeons provided interpreta-
tion of the results of the ultrasound imaging and cerebral
angiography; radiologists provided interpretation of the
MRA.
Contraindications to stenting were subject to operator
discretion and included excessive calcification of the target
lesion, severe tortuosity of the cerebral vasculature, contra-
indication to administration of plavix, and small internal
carotid diameter precluding placement of a stent.In order to monitor the patient’s neurologic status
continuously throughout the procedure, the procedures
were performed using local anesthesia without sedation.
The common femoral artery was used to obtain vascular
access and cerebral angiography was performed to confirm
the degree of carotid stenosis. Unfractionated heparin was
administered intravenously to maintain an activated clot-
ting time of 250 seconds. The patients were placed on
clopidogrel 75 mg for 5 days prior to stenting, or 300 mg
loading dose 4 hours prior to carotid stenting.
A wide range of stents and protection devices were
used, reflecting the evolution of available devices and in-
volvement in clinical trials (Tables I and II). Cerebral
protection devices and self-expanding stents were placed in
all patients. The lesions were routinely pre- and post-
dilated with a rapid exchange system angioplasty balloon
chosen during the procedure at the operator’s discretion
Table I. Carotid stent sizes and angioplasty balloon
characteristics
Characteristics Male Female P value
Pre-dilatation balloon
diameter (mm) n  125 n  83
2-2.5 3 3 .68
3-3.5 11 5 .59
4 111 70 .40
5-6 0 5 .009
Pre-dilatation balloon
length (mm) n  68 n  38
20 24 21 .06
30-35 1 1 .99
40 43 16 .04
Stent diameter (mm) n  96 n  64
Tapered n  31 n  24 .50
6  8 6 6 .54
7  10 25 15 .85
Other (7  7, 7  9,
8  10) 0 3 (1 each) .06
Straight n  65 n  40 .50
5 3 1 .99
6 2 1 .99
7 2 6 .051
8 20 15 .53
9 12 4 .28
10 26 13 .53
Stent length (mm) n  86 n  60
30 61 50 .11
40 25 10 .11
Post-dilatation balloon
diameter (mm) n  128 n  85
4 2 2 .99
5 21 56 1.88 e-13
5.5 95 25 1.07 e-10
6 9 1 .053
7 1 1 .99
Post-dilatation balloon
length (mm) n  69 n  46
20 48 36 .39
30 8 0 .02
40 13 9 .99
50-60 0 1 .04(Table I). The stent and angioplasty balloon lengths and
JOURNAL OF VASCULAR SURGERY
Volume 49, Number 2 Goldstein et al 317diameters employed for each patient were retrospectively
collected as available and entered into our database for
review. Until 2005, 0.5 mg of atropine was routinely
administered intravenously regardless of the nature of the
lesion, prior to pre-dilation to minimize the parasympa-
thetic response. After 2005, atropine was replaced with 0.2
to 0.4 mg of glycopyrrholate, given in a similar manner. All
patients were maintained on 325 mg of aspirin daily and 75
mg of clopidogrel during the postoperative period. Clopi-
dogrel was discontinued 30 days after the procedure unless
there were other reasons necessitating its continuation.
Patients were maintained indefinitely on a daily dose of
aspirin.
Angiographic data was retrospectively reviewed and
recorded on a Leonardo workstation (Siemens Medical,
Munich, Germany). Image measurements were quantified
by calibrating the system using a table-object distance
calibration, supplied as a software function of the worksta-
tion which calculates a calibration factor on the basis of
image geometry. Arterial anatomic characteristics evaluated
using angiographic images were: aortic arch elongation
classification, aortic arch calcification, index lesion calcifica-
tion, common carotid diameter, internal carotid diameter,
index lesion length, common carotid/internal carotid le-
sion length ratio, common carotid tortuosity, and internal
carotid tortuosity. Internal carotid diameter was measured
at the first point in the artery distal to the lesion at which the
arterial walls became parallel. The aortic arch elongation
classification was defined by the location of the origin of the
arch vessels: arising from the top of the arch (class I),
between the parallel planes delineated by the outer and
inner curves of the arch (class II), and caudal to the inner
surface of the arch or off the ascending aorta (class III).17
Aortic arch calcification was classified as no calcium present,
Table II. Carotid stent systems and cerebral protection
devices
Characteristics Male Female P value
Stent n  141 n  97
Closed Cell n  41 (29.1%) n  27 (27.8%) .88
Wallstent 23 (56.1%) 18 (66.7%) .45
Nex Stent 17 (41.5%) 6 (22.2%) .12
Xact 1 (2.4%) 3 (11.1%) .30
Open Cell n  94 (66.7%) n  67 (69.1%) .78
Precise 23 (24.5%) 12 (17.9%) .34
Acculink 64 (68.1%) 47 (70.1%) .86
Maverick
(exponent) 1 (1.1%) 2 (3.0%) .57
Vivex 4 (4.2%) 4 (6.0%) .72
Protege 2 (2.1%) 2 (3.0%) .99
Unknown n  6 (4.2%) n  3 (3.1%) .74
Protection Device n  141 n  97
Percusurge 16 (11.3%) 21 (21.6%) .04
Epi Filter Wire 44 (31.2%) 22 (22.7%) .18
Accunet 49 (34.7%) 37 (38.1%) .68
Angioguard 23 (16.3%) 9 (9.3%) .13
Emboshield 7 (5.0%) 6 (6.2%) .77
Spider Filter 2 (1.4%) 2 (2.1%) .99single arch surface with calcified irregularity (mild to mod-erate), or significant calcification of both luminal arch sur-
faces (severe). Lesion calcification was classified in a similar
manner with regard to the luminal surfaces of the index
lesion (none, mild-moderate, severe). Vessel tortuosity was
graded in three groups: vessels with30 degree angulation
from the centerline of blood flow, 30-60 degree angula-
tion, and 60 degree angulation. A bovine arch configu-
ration was defined as the innominate artery and left com-
mon carotid artery either originating from a common
orifice, or the left common carotid artery originating as a
branch of the innominate artery. Of these anatomic fea-
tures, the individual surgeon recorded the degree of steno-
sis of the index lesion, the presence and degree of lesion
calcification, and the anatomic specifics of the aortic arch at
the time of the procedure in a prospective manner. The
authors of this paper collected other angiographic data
retrospectively from existing archived angiographic images.
Procedures, complications, demographics, co-morbidities,
angiographic characteristics, and follow-up data were en-
tered into a prospective database for review (Microsoft
Excel, Microsoft Corp, Redmond, Wash). Categorical data
was compared between groups using the Fisher’s Exact
Test. Kaplan-Meier curves for survival, stroke-free survival,
and long-term carotid patency were compared using the
log rank test.
RESULTS
Demographics. A total of 238 interventions were per-
formed on 228 patients from 2003 to 2008 at New York
Presbyterian Hospital. A total of 141 interventions were
performed on 135 males, and 97 interventions were per-
formed on 93 females. Preoperative demographics col-
lected are listed in Table III. The mean age was 72.2 9.1
years for males (range, 51-93), and 71.8  9.2 years for
females (range, 46-94) (P  .99). Forty-nine males
(34.7%) and 43 females (44.3%) were symptomatic at the
time of their presentation (P  .14). Only the presence of
hypertension, history of smoking, and the history of a
Table III. Patient demographics
Males Females P value
Mean age (years) 72.2  9.1 71.8  9.2 .99
Hypertension 112 (83.0%) 90 (96.7%) .001
Hypercholesterolemia 89 (65.9%) 68 (73.1%) .31
CABG 43 (31.8%) 15 (16.1%) .01
Coronary disease 89 (65.9%) 50 (53.7%) .07
Previous MI 30 (22.2%) 18 (19.3%) .62
Diabetes 38 (28.1%) 29 (31.1%) .66
PVD 27 (20.0%) 20 (21.5%) .87
Smoker 89 (65.9%) 48 (51.6%) .04
Cancer history 38 (28.1%) 20 (21.5%) .28
Previous ipsilateral CEA 13 (9.6%) 16 (16.4%) .11
Previous contralateral CEA 8 (5.9%) 9 (9.2%) .31
Symptomatic 49 (34.7%) 43 (44.3%) .14
Contralateral occlusion 15 (10.6%) 9 (9.3%) .83
CABG, Coronary artery bypass grafting; MI, myocardial infarction; PVD,
peripheral vascular disease; CEA, carotid endarterectomy.previous coronary artery bypass grafting (CABG) were
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tween men and women. Women were more likely to have
hypertension compared to men (96.7% vs 83.0%, P 
.001). Interestingly, while there was no statistically signifi-
cant difference in the history of coronary disease (defined as
a prior myocardial infarction [MI] or acute coronary event,
positive stress test, angina, ischemic cardiomyopathy, or
documented cardiac catheterization findings), men were
more likely than women to have undergone CABG (31.8%
vs 16.1%, P  .01). Men were also more likely to be
smokers (65.9% vs 51.6%, P  .04).
Angiographic characteristics. Prospective angiographic
data was collected and supplemented with retrospective an-
giographic review, and was available as follows: common
carotid tortuosity for 186 procedures, internal carotid tor-
tuosity for 208 procedures, lesion calcification for 216
procedures, arch elongation type for 223 procedures, bo-
vine arch configuration for 226 procedures, and arch calci-
fication for 211 procedures. Retrospective angiographic re-
view was used when available to obtain the internal and
common carotid artery diameters, the internal to common
carotid artery diameter ratio, and the extent of the lesion
distribution for 149 procedures. There were no significant
differences for any of these traits between men and women in
Table IV. Angiographic lesion characteristics
Characteristics Males
Lesion calcium
None 63 (48.8%)
Mild-moderate 43 (33.3%)
Severe 23 (17.8%)
Mean ICA diameter (mm) 4.2  1.0
Mean CCA diameter (mm) 6.9  1.4
ICA/CCA diameter ratio 0.62
Lesion distribution
CCA only 6 (6.9%)
Mean length (mm) 17.4  6.5 (8.7-24
CCA  ICA 30 (34.8%)
Mean length (mm) 15.0  6.1 (2.3-26
ICA only 50 (58.1%)
Mean length (mm) 10.9  4.8 (1.6-22
Length in ICA/total length 0.78
Common carotid tortuosity
0-30 74 (64.9%)
30-60 25 (21.9%)
60 10 (8.7%)
Internal carotid tortuosity
0-30 49 (40.1%)
30-60 36 (29.5%)
60 37 (30.3%)
Arch calcium
None 79 (63.2%)
Mild-mod 36 (28.8%)
Severe 10 (8.0%)
Bovine arch configuration 29 (21.8%)
Arch type
1 56 (44.8%)
2 57 (45.6%)
3 12 (9.6%)
ICA, Internal carotid artery; CCA, common carotid artery.our cohort. The mean ICA diameter was 4.2  1.0 mm formales vs 3.9  0.8 mm for females (P  .99). Women were
more likely than men to have a carotid lesion confined with
the common carotid, however, this trend did not become
statistically significant (9.5% vs 6.9% P .76) (Table IV).
Retrospective analysis of the stent systems and cerebral
protection devices employed revealed no difference be-
tween genders in the use of straight vs tapered stents, or
closed vs open cell designed stent systems (Tables I and II).
Women were significantly more likely to have had a 5 mm
post-dilatation balloon employed vs men (56 vs 21, P 
.0001) while men were more likely to have had a 5.5 mm
post-dilatation balloon employed vs women (95 vs 25, P
.0001) (Table I).
Procedural outcomes. Postoperative data is listed in
Table V. Local groin complications occurred with low
frequency in both men and women. Men had five hemato-
mas, and females had four (3.5% vs 4.1%, P  .99). Pseu-
doaneurysm occurred in one male and one female (0.7% vs
0.1%, P  .99). There were six strokes in males (4.2%),
including four minor strokes and two major strokes, and
two strokes in females (2.1%), including one minor stroke
and one major stroke (P  .48 for men vs women). One
minor stroke occurred in a male who also went on to suffer
an MI, and one major stroke in a male resulted in a
Females P value
46 (52.8%) .58
26 (29.9%) .65
15 (17.2%) .99
3.9  0.8 .99
6.0  1.1 .77
0.65 .99
6 (9.5%) .76
14.5  8.4 (4.6-27.6) .99
20 (31.7%) .72
15.4  6.0 (8.6-28.7) .48
37 (58.7%) .99
9.5  5.3 (1.7-26.2) .99
0.79 .99
49 (63.6%) .87
23 (29.8%) .23
5 (6.4%) .78
24 (27.5%) .07
31 (35.6%) .37
32 (36.7%) .37
52 (60.4%) .77
25 (29.0%) .99
9 (10.4%) .62
25 (26.8%) .42
39 (42.8%) .78
45 (49.6%) .58
7 (7.6%) .80.5)
.6)
.6)mortality. The 30-day mortality rate in our series for all
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no deaths occurring in females. Three females (3.1%) suf-
fered an MI, compared to one male (0.7%), (P  .3). The
combined stroke, death, and MI rate was 5.7% for males
compared to 5.4% for females (P  .99). There was no
difference in the requirement for postoperative hemody-
namic pressor therapy related to carotid bulb insult (de-
fined as requiring an infusion of epinephrine, norepineph-
rine, dopamine, or phenylephrine to maintain adequate
arterial blood pressure at the discretion of the operator for
any length of time), or postoperative length of stay.
Follow-up. Patients were followed with clinic visits
and carotid duplex at 1 month postoperatively and then 3,
6, and 12 months postoperatively and yearly thereafter.
Follow-up duplex scans were available for 111 of 141 males
and for 72 of 97 females, with a mean follow-up time of
15.6  15.6 months (range, 0 to 68 months). Kaplan-
Meier analysis of duplex scan-assessed restenosis (50%
luminal reduction, also assessed using the University of
Washington duplex scan criteria)15,16 revealed no signifi-
cant differences between men and women (Fig 1, P .92).
Only 1 male patient in the series (and no female patients)
demonstrated a greater than 70% restenosis which occurred
7.5 months following his CAS. He remained asymptomatic
and he underwent repeat CAS, which again progressed to
greater than 70% stenosis in just 4 months after the second
intervention, after which the patient was lost to follow-up.
Mean clinical follow-up was 22.3  17.4 months
(range, 0 to 68 months). During our follow-up period, 24
men and 15 women died. One-year survival was 93.0% for
men and 94.4% for women, and 3-year survival was 76.3%
for men and 75.0% for women. Kaplan-Meier survival
analysis demonstrated no difference in long-term survival
between men and women (P  .47) (Fig 2).
During the follow-up period, two women developed
neurologic events. One patient experienced mild neuro-
logic symptoms 15 months after the carotid intervention
with symptoms largely improving with medical manage-
ment. The second woman sustained an ischemic stroke
manifested by upper and lower extremity paresis and apha-
Table V. Postoperative patient data
Males Females P value
Hematoma 5 (3.5%) 4 (4.1%) .99
Pseudoaneurysm 1 (0.7%) 1 (0.1%) .99
Stroke 6 (4.2%) 2 (2.1%) .48
4 minor, 2 major 1 minor, 1 major
Death 1 (0.7%) 0 .99
MI 1 (0.7%) 3 (3.2%) .30
Stroke/death/MI 8 (5.7%) 5 (5.4%) .99
Postoperative
pressors 20 (14.2%) 17 (17.5%) .46
Average LOS
(days) 2.0  1.6 1.6  1.3 .99
LOS (1 day only) 101 (71.6%) 67 (69.0%) .99
MI, Myocardial infarction; LOS, length of stay.sia 32 days after the carotid stenting. Thrombolytic treat-ment in another hospital led to a severely debilitating
hemorrhagic stroke. The patient never recovered from the
dense neurologic symptoms. One man experienced aphasia
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Fig 1. Kaplan-Meier plot of men versus women demonstrating
greater than 50% restenosis by duplex ultrasonography scan fol-
lowing carotid angioplasty and stenting. There is no difference in
long-term restenosis seen between genders (P  .92). CAS, Ca-
rotid artery stenting.
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Fig 2. Kaplan-Meier survival curve following carotid angioplasty
and stenting. There is no long-term survival difference between
men and women (P  .47). CAS, Carotid artery stenting.and paraplegia 2 years after the initial procedure due to an
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man who developed late-onset neurologic symptoms, du-
plex ultrasonography scan verified stent patency after the
onset of their symptoms. Kaplan-Meier analysis demon-
strated no difference in stroke-free survival between men
and women throughout our follow-up period (P  .48)
(Fig 3).
DISCUSSION
This study looked specifically at the outcomes at our
institution of carotid angioplasty and stenting by gender. In
our cohort, women undergoing CAS comprised a similar
patient population as men and shared similar angiographic
characteristics of their arteries and lesions as men. Com-
pared tomen,womenhad no statistically significant difference
in technical outcomes from the procedure, with similar peri-
procedural cardiovascular andneurologic event rates, procedure-
associated mortality, short hospital lengths of stay, and low
rates of local groin complications.Menwere found to bemore
likely to have undergone CABG in our patient population.
While a higher percentage of men presented with coronary
disease, there was not a significant difference between gen-
ders. From our data it is unclear whether the observed dispar-
ity between the twogenders in surgically treating patientswith
coronary disease actually reflects a different severity of coro-
nary disease or a tendency to undertreat females with coronary
disease.
In our cohort, we did not observe any statistically
significant gender-associated difference in the plaque area or
distribution. This contrasts with the findings of other authors.
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Fig 3. Kaplan-Meier stroke-free survival curve following angio-
plasty and stenting. There is no difference in long-term stroke free
survival between men and women (P  .48). CAS, Carotid artery
stenting.Indeed, Schulz and Rothwell18 showed that women hadbetter carotid outflow ratios, with a larger internal carotid
artery/common carotid artery (ICA/CCA) diameter ratio
than men (0.67 vs 0.62), and men were more likely to have
disease distal to the carotid bulb while women were more
likely than men to have a stenotic lesion within the com-
mon carotid. Our study found women to have a larger
ICA/CCA ratio as well (0.65 vs 0.62), however, this did
not reach significance presumably in part due to our sample
size (nearly one-eighth that of Schulz and Rothwell) and
the fact that the previous study only examined vessels with
less than a 50% stenosis (perhaps skewing their results). We
also found women more likely than men to have a stenotic
lesion localized in the common carotid (9.5% vs 6.9%),
however, this trend did not become statistically significant
(P .76) likely due to the small sample for comparison and
the fact that such lesions within the common carotid are
technically more challenging and thus less favorable for
carotid stenting. Iemolo et al19 studied gender differences
in carotid plaques and stenosis, and found women to have
more focal lesions when compared to men. We did not
identify such differences in our study, again most likely due
to selection bias since focal lesions are more preferable for
angioplasty.
We also did not find a statistically significant difference
in the mean diameter of the ICA between genders in our
study (4.2 mm 1.0 for men vs 3.9 mm 0.8 for women,
P  .99). Gender-related difference in internal carotid size
has been reported in the existing literature: Goubergrits et
al20 looked at post-mortem vessel casts of carotid arteries
and did find smaller diameters in women for absolute
measurements of the ICA, but that difference disappeared
once normalized against the common carotid diameter.
Smaller carotid arteries in women have also been confirmed
clinically using ultrasound scans by other authors including
Hansen et al21 and Williams et al.22 Our cohort represents
a group of patients who received carotid stents, potentially
excluding women with smaller internal carotid arteries who
may have been unsuitable for carotid stenting. Despite our
measured similarity in ICA diameters, women were signif-
icantly more likely to have had a 5 mm post-dilatation
balloon employed vs men, while men were more likely to
have had a 5.5 mm post-dilatation balloon employed vs
women. The operator made the choice of post-dilatation
balloon size at the time of the procedure, and this finding
may be related to preconceived notions regarding the sizes
of arteries between genders.
The large randomized trials that have looked at the
efficacy of carotid endarterectomy in preventing stroke in
both symptomatic and asymptomatic patients as empha-
sized above, have either failed to show a significant benefit
for women, or failed to specifically analyze gender as a
subgroup. NASCET and ECST did not initially report
gender subgroup analysis.2,3 The CETC analysis of symp-
tomatic patients showed that men with 70% stenosis
benefit from surgery even after 12 weeks, while women
only benefit if operated on in less than 2 weeks after the
onset of symptoms.11 The asymptomatic trials fared no
better, with ACAS reporting a 5-year relative stroke-risk
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36% to 82%) and for women a statistically insignificant 17%
5-year relative stroke-risk reduction (95% CI, 96% to
65%).1 They attributed this discrepancy to the higher peri-
operative complication rate seen in women compared to
men (3.6% vs 1.7%, P  .12), yet among patients not
suffering a perioperative event, the relative stroke-risk re-
duction of 56% was still not significant for women (56%,
95% CI,50% to 87%), despite a strong reduction for men
of 79% (95% CI, 52% to 91%).1 ACST touted a long-term
non-perioperative risk reduction for women of 4.1%, but
when compared to the perioperative stroke and death rate
of 3.8%, there seemed little benefit to CEA in asymptomatic
women.5 This increased perioperative risk has also been
demonstrated in retrospective single institution studies,23
while other groups have concluded that CEA is equally safe
and beneficial in women as in men.24-26 Rockman et al27
demonstrated retrospectively that CEA could be performed
safely with similarly low perioperative stroke rates for both
genders (2.3% for men vs 2.4% for women, P .92). Lee et
al28 added support to this with their cohort of patients who
also demonstrated the safety of performing CEA in asymp-
tomatic females, and similar conclusions were made by
Mattos et al,24 and Schneider et al.25 These studies were
not randomized, and did not take into account the compli-
cation rate attributable to perioperative arteriography in the
ACAS trial.
The SAPPHIRE trial was the first stenting trial to show
non-inferiority of CAS to CEA in high-risk patients, but
women were under-represented within the recruited pop-
ulation. Furthermore, the study did not analyze data or
compare outcomes for gender subgroups.6,12 Regarding
regular-risk patients with a high degree of symptomatic
carotid stenoses, the more recent SPACE and EVA 3-S
trials not only failed to show non-inferiority, but also had
significantly higher rates of stroke and death than contem-
porary series for endarterectomy.29 Women demonstrated
a higher absolute risk difference between CAS and CEA
than men for primary endpoint events in the SPACE trial
1.71 (90% CI3.63 to 6.53) vs 0.04 (90% CI2.80
to 2.86).7 Both trials have been criticized for not meeting
the intended number of randomized patients, not utilizing
cerebral protection devices for all patients, and for varying
experience of the operators performing the interventions.
From all of these randomized trials comparing stenting to
endarterectomy, only the Carotid Revascularization End-
arterectomy vs Stenting Trial (CREST) is designed to
provide gender-specific outcomes with subgroup analysis
but it is ongoing for now.
Therefore, until we have such data from the CREST
trial or other future randomized prospective studies, the
unsettled debate regarding the safety and efficacy of carotid
stenting and our gender-specific management strategy as
interventionalists should be based on information derived
from smaller existing trials and registries. As in our study,
Roubin et al30 also found men and women to have similar
peri-procedural complication rates (8.0% vs 5.9%, respec-
tively; P  .4) when undergoing carotid stenting. Eskan-dari et al31 looked at 44 women and 123men and had both
a major and minor stroke rate of 1.1%, with no appreciable
differences noted between genders, though the absolute
numbers of strokes occurring between the genders were
not detailed. Park et al32 retrospectively looked at 42
women and 47 men undergoing carotid stenting and 40
women and 53 men undergoing carotid endarterectomy
during the same period. They reported a 0% perioperative
stroke rate in men and 2% in women, but this difference did
not reach statistical significance. They had no deaths and no
coronary events in the carotid stenting group. Interestingly
they found no statistically significant difference between
genders in any of the outcomes in the carotid endarterec-
tomy arm of the study, although their reported incidence of
MI after endarterectomy was 2% for men and 5% for
women.
The addition of this larger cohort of patients in our
study strengthens the findings of these previous studies
with similar results. Eskandari also observed higher rates of
clinically significant restenosis in women (all three observed
lesions in their study occurred in females), which was not
supported by our findings. In our opinion, although there
is significant evidence that carotid endarterectomy in
women is strongly associated with higher rates of resteno-
sis, this might not hold true for carotid stenting.33,34
Women have been shown to have better outflow to inflow
ratios and higher carotid velocities than men.18,35,36 Both
of these features should theoretically have a negative impact
on the development of restenosis after stenting, but this
needs further investigation. Finally, our results agree with
the data collected and published in the ongoing Italian and
German Registry: In 2007 the published data from CAS
procedures performed in 179 women and 516men showed
no statistically significant difference in perioperative major
stroke rate (1.1% vs 1.6%), death (0% vs 1.6%) and com-
bined stroke/death adverse event rate (3.4% vs 4.1%).37
There are several limitations to our study: it is a non-
randomized, retrospective study, and patient inclusion,
preoperative evaluation of the carotid lesion, and decisions
during the intervention that might affect the outcome were
all subject to each operator’s discretion. This causes many
biases typical for this type of study regardless of the careful
data collection and analysis performed by the authors.
Moreover, retrospective data collection has its own flaws as
the same type and amount of information is not available
for all patients and, therefore, some demographic, angio-
graphic, procedural, and outcome data are missing for the
final analysis. However, as CAS is a relatively new procedure
and there are no randomized trials to answer questions
regarding the impact of gender on carotid stenting, our
study, being one of the largest of its kind, should provide
useful information regarding carotid stenting in women.
In addition, our long-term data are derived from a
relatively short follow-up period with an average duration
of 15.6 months. Few of our patients have a shorter follow-up
of only 3 months and thus the Kaplan-Meier curves are
limited. However, it is known that restenosis due to intimal
hyperplasia occurs within the first 12-18 months after the
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tically significant difference in late occurring events or
restenoses between the genders within this period. Future
studies with longer follow-up are necessary to evaluate the
long-term impact of the carotid stenting in the natural
history of the disease in the different genders.
CONCLUSION
In conclusion, this study is one of the first and largest to
address the issue of carotid angioplasty and stenting with
regard to outcome by gender. We have found CAS to be
safe, with similar angiographic characteristics between gen-
ders, and similar perioperative outcomes. Future random-
ized studies would be necessary to answer the question of
how women and men may differently respond to vascular
interventions in each of the vascular beds in which we
intervene.
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DrWei Zhou (Stanford, Calif). My first question is regarding
compatibility of the two groups of patients. Several risk factors
including congestive heart failure (CHF), chronic renal failure, and
chronic obstructive pulmonary disease (COPD) are known to
negatively impact carotid interventions, but these were not evalu-
ated in this study. Based on the Kaplan-Meier survival curve of your
patients, male patients had a significant drop out at 6 months while
female patients tended to drop out around 20 months. So my first
question is whether you really compared similar groups of patients?
Is outcome of carotid artery stenting (CAS) for female patients
truly equivocal to men, or they are just healthier than their male
counterparts?
You mentioned that the indications for significant stenosis
were based on ultrasound scan, magnetic resonance angiography
(MRA), and carotid angiogram. Giving the fact that MRA tends to
overestimate the lesions and ultrasound scan is a fairly good
non-invasive screen tool, my second question is: Why an ultra-
sound scan was not used for all patients and were those imaging
studies validated and cross-referenced?
In your manuscript, you mentioned that the size of your
predilatation balloon was uniformly 4 mm  50 mm. The size is a
little bigger than most surgeons would have used. Were there any
reasons for oversizing the predilatation balloon?
The last question is regarding ultrasound scan characteristics
of lesions. Studies have shown that ultrasound scan characteristics
are important, maybe more so than the degree of stenosis. Have
you looked into and will you plan to evaluate ultrasound scan
characteristics of the lesion in the future?
Dr Lee Goldstein. To begin, let me address your first ques-
tion. As far as other preoperative characteristics, we have been
actively trying to pursue the maintenance of our dataset and we
have been trying to add to some of the preoperative characteristics.
I agree, one of the troubles we’ve had has been many of the
patients we’ve done our carotid angioplasty and stenting on have
come as referrals from other medical centers, so we have been
trying to look back and get more data on these patients. Adding
things like congestive heart failure, renal failure, and COPDwould
shed some light on whether or not these patients are different.
One thing that struck us was the remarkable similarity be-
tween our patient populations. As we processed this data, we were
surprised to see just how close they were, that we saw so few
differences. So I agree, adding more data points will be helpful and
we will go back and try to do that.
With regard to preoperative workup, I don’t have the break-
down as to which patients were evaluated preoperatively by MRA
angiography vs ultrasound. Anecdotally, I can tell you the vast
majority of these patients were evaluated with a preoperative
ultrasound scan and then that was confirmed with or without an
MRA or angiography. Every one of them underwent angiography
prior to the placement of a carotid stent during the procedure, so
the lesion was confirmed intraoperatively prior to placement of the
carotid stent. I don’t think any of them had solely an MRA. But
they all had a preoperative duplex scan and then a preplacementWith regard to the predilatation balloon, that may be an error
in the manuscript. I believe it’s a 4  20 balloon. And we’ll make
sure that we address that.
And lastly, as far as ultrasound scan characteristics, I think
that there has been some recent literature looking both at
specifically female-related ultrasound scan characteristics, that
females demonstrate higher velocities with regard to specific
lesion characteristics, and that females will demonstrate higher
velocities for specific stenosis sizes. We have not yet gone back
and evaluated our particular ultrasound scan characteristics for
these patients.
Additionally, there has been some new data looking at evalu-
ation of post carotid stenting ultrasound scan characteristics and
velocities. We can go back and look specifically at those issues as
well.
Dr Anil Hingorani (Brooklyn, NY). How many of your
patients that had strokes didn’t have embolic protection devices,
and why didn’t they?
Dr Goldstein. There were no patients that suffered a stroke
that didn’t have an embolic protection device.
Dr Hingorani. You had a fair number that didn’t have
embolic protection devices used. What were the reasons?
Dr Goldstein. There were 13 patients in the study without
embolic protection devices. I don’t know the reasons why they
didn’t at the time.
Dr Hingorani. All of the strokes occurred without embolic
protection?
DrGoldstein.No. Every patient who suffered a stroke had an
embolic protection device placed.
Dr Karl Illig (Rochester, NY). Dr. Goldstein, luckily your
ages are the same in each group so your conclusions aren’t affected,
but can you defend your choice of age over 80 as a high-risk criteria
for surgery or, in other words, why you feel stenting is safer than
endarterectomy in elderly patients? I would say the opposite is true.
DrGoldstein. I would agree. I don’t know. This has been the
high-risk group that has been used for our institution in our carotid
stenting group.
Dr Illig. Can you defend that?
Dr Ageliki Vouyouka (New York, NY). The data collection
of this study started early in 2003. At that time, the worst out-
comes from carotid stenting in octogenarians, as shown in the lead
in phase of the CREST trial, were not yet known. Therefore,
initially, one of the high-risk criteria to consider carotid stenting
was age 80 years. This criterion was abandoned in later years.
Dr Taras Kucher (Trumbull, Conn). In this study, both
males and females had approximately 4-mm size carotid arteries. It
is postulated in prior publications, that the increased risk of com-
plications in women (particularly re-stenosis) is secondary to
smaller size of the vessels. Do you have an explanation for this
discrepancy?
Dr Goldstein. Correct. We’ve noted a number of papers that
have demonstrated women to have smaller carotid arteries. In fact,
that’s the hypothesis as to why they’ve done poorly surgically, that
technically they’ve had harder arteries to work with and why
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independently to review the angiographic data and they got similar
measurements. So I can’t explain why our cohort had these results,
but we had in fact similar sizes between themen and the women forWe did have similar findings as other groups, although they
didn’t reach significance, for internal carotid to common carotid
ratios, and for outflow to inflow ratios for women compared to
men. But as far as absolute sizes, we did not demonstrate athe internal carotids. difference between men and women.
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